ABIVAX Société Anonyme (0RA9.L)

EUR 6.51

(0.46%)

Revenue Summary of ABIVAX Société Anonyme

ABIVAX Société Anonyme's latest annual revenue in 2023 was 4.62 Million EUR , up 0.83% from previous year.
ABIVAX Société Anonyme's latest quarterly revenue in 2024 Q2 was 6.78 Million EUR , down 0.0% from previous quarter.
ABIVAX Société Anonyme reported a annual revenue of 4.58 Million EUR in annual revenue 2022, up 12286.49% from previous year.
ABIVAX Société Anonyme reported a annual revenue of 37 Thousand EUR in annual revenue 2021, up 164.29% from previous year.
ABIVAX Société Anonyme reported a quarterly revenue of 2.24 Million EUR for 2023 Q2, down 0.0% from previous quarter.
ABIVAX Société Anonyme reported a quarterly revenue of 2.24 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of ABIVAX Société Anonyme (2023 - 2013)

Historical Annual Revenue of ABIVAX Société Anonyme (2023 - 2013)

Year	Revenue	Revenue Growth
2023	4.62 Million EUR	0.83%
2022	4.58 Million EUR	12286.49%
2021	37 Thousand EUR	164.29%
2020	14 Thousand EUR	300.0%
2019	-7000.00 EUR	-100.86%
2018	815 Thousand EUR	128.93%
2017	356 Thousand EUR	135.76%
2016	151 Thousand EUR	-33.77%
2015	228 Thousand EUR	239.62%
2014	67.13 Thousand EUR	-10.33%
2013	74.87 Thousand EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q2	6.78 Million EUR	0.0%
2023 Q2	2.24 Million EUR	0.0%
2023 Q4	2.24 Million EUR	0.0%
2023 FY	4.62 Million EUR	0.83%
2022 Q4	2.24 Million EUR	0.0%
2022 FY	4.58 Million EUR	12286.49%
2022 Q2	2.22 Million EUR	0.0%
2021 FY	37 Thousand EUR	164.29%
2021 Q4	- EUR	0.0%
2021 Q2	- EUR	0.0%
2020 Q4	14 Thousand EUR	0.0%
2020 Q2	- EUR	0.0%
2020 FY	14 Thousand EUR	300.0%
2019 Q2	40 Thousand EUR	0.0%
2019 FY	-7000.00 EUR	-100.86%
2019 Q4	-47 Thousand EUR	0.0%
2018 Q4	323 Thousand EUR	0.0%
2018 FY	815 Thousand EUR	128.93%
2018 Q2	492 Thousand EUR	0.0%
2017 Q2	4000.00 EUR	0.0%
2017 FY	356 Thousand EUR	135.76%
2017 Q4	352 Thousand EUR	0.0%
2016 Q4	14 Thousand EUR	0.0%
2016 Q2	137 Thousand EUR	0.0%
2016 FY	151 Thousand EUR	-33.77%
2015 FY	228 Thousand EUR	239.62%
2015 Q4	-82 Thousand EUR	0.0%
2015 Q2	310 Thousand EUR	0.0%
2014 Q4	189 Thousand EUR	199900.0%
2014 Q2	- EUR	0.0%
2014 Q1	- EUR	0.0%
2014 FY	67.13 Thousand EUR	-10.33%
2014 Q3	94.50 EUR	0.0%
2013 FY	74.87 Thousand EUR	0.0%

Peer Revenue Comparison of ABIVAX Société Anonyme

Name	Revenue	Revenue Difference
Boiron SA	493.24 Million EUR	99.063%
Laboratorios Farmaceuticos Rovi, S.A.	829.5 Million EUR	99.443%
Vetoquinol SA	529.27 Million EUR	99.127%
Valneva SE	153.71 Million EUR	96.994%
AB Science S.A.	970 Thousand EUR	-376.392%
Nanobiotix S.A.	30.05 Million EUR	84.626%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	-248.492%
Vivoryon Therapeutics N.V.	-3.62 Million EUR	227.652%
BioSenic S.A.	543 Thousand EUR	-751.013%
Formycon AG	77.69 Million EUR	94.052%